Catalyst Wire Dossier Catalyst Wire Dossier

Rifamycin SV MMX Multi-Matrix System

rifamycin SV · Cosmo Technologies Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rifamycin SV MMX Multi-Matrix System, covering 2018-04-10 to 2018-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) [Phase 3]

See pricing